Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice
Alzheimer’s disease (AD), characterized by cognitive impairments, is considered to be one of the most widespread chronic neurodegenerative diseases worldwide. We recently introduced a novel therapeutic agent for AD treatment, the T-type calcium channel enhancer ethyl-8-methyl-2,4-dioxo-2-(piperidin-...
Main Authors: | Dian Yuan, An Cheng, Ichiro Kawahata, Hisanao Izumi, Jing Xu, Kohji Fukunaga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/2/741 |
Similar Items
-
T-type Ca2+ channel enhancer SAK3 administration improves the BPSD-like behaviors in AppNL−G-F/NL−G-F knock-in mice
by: Tomohide Degawa, et al.
Published: (2021-05-01) -
T-Type Ca<sup>2+</sup> Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model
by: Jing Xu, et al.
Published: (2021-06-01) -
Sak Uwong Sak Uwit for Environmental Protection Based on Local Wisdom: An Environmental Law Reform in Indonesia
by: Ridwanto Ardi Kusumo, et al.
Published: (2020-01-01) -
The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome
by: Udaiyappan Janakiraman, et al.
Published: (2020-09-01) -
Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency
by: Chinnasamy Dhanalakshmi, et al.
Published: (2021-02-01)